Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine, Phentolamine, and Combination for Cyclopentolate Reversal in Children
NCT07012512Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised trial of pilocarpine and phentolamine in Mydriasis and cycloplegia (3 arms), sponsored by Mansoura University. Primary endpoint: Reversal of pupillary dilatation at 4 hours. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
pilocarpinephentolamine
03
Conditions
Mydriasiscycloplegia
Beyond the preview
Go deeper on NCT07012512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07012512.